Aeterna Zentaris
AEZS
#10198
Rank
S$22.69 M
Marketcap
S$7.41
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

EPS for Aeterna Zentaris (AEZS)

EPS in 2024 (TTM): S-$2.77

According to Aeterna Zentaris's latest financial reports the company's current EPS (TTM) is S-$2.66. In 2022 the company made an earnings per share (EPS) of S-$6.06 a decrease over its 2021 EPS that were of S-$2.36.

EPS history for Aeterna Zentaris from 1998 to 2024

Annual EPS

Year EPS Change
2024 (TTM)S-$2.77
2022S-$6.06157.14%
2021S-$2.36-41.48%
2020S-$4.03-64.46%
2019S-$11.34-240%
2018S$8.10-122.32%
2017S-$36.29-53.53%
2016S-$78.08-86.71%
2015S-$587.69-35.21%
2014S-$907.13-216.67%
2013S$777.54-123.3%
2012S-$3,337-40.8%
2011S-$5,637-6.45%
2010S-$6,026-27.91%
2009S-$8,359-61.61%
2008S-$21,77183.61%
2007S-$11,857-195.31%
2006S$12,441178.26%
2005S$4,471-330%
2004S-$1,944-80.05%
2003S-$9,74317.78%
2002S-$8,273515.93%
2001S-$1,343-68.6%
2000S-$4,278119.62%
1999S-$1,948-3.63%
1998S-$2,021

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Spectrum Pharmaceuticals
SPPI
S-$0.47-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$9.54-459.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Bristol-Myers Squibb
BMY
S$3.85-244.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$4.80-280.86%๐Ÿ‡ซ๐Ÿ‡ท France
Halozyme Therapeutics
HALO
S$6.34-338.66%๐Ÿ‡บ๐Ÿ‡ธ USA